On 2025-05-13, Kezar Life Sciences, Inc. (KZR) announced earnings per share of $-2.27 for the fiscal quarter ending 2025-03-31, beating the average analyst estimate of $-2.56.
The next expected annoucement date for quarterly earnings is 2025-08-12, with an average estimated earnings per share of $-2.25 for the fiscal quarter ending 2025-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-05-13 | 2025-03-31 | $-2.56 | $-2.27 |
| 2025-03-25 | 2024-12-31 | $-2.71 | $-2.77 |
| 2024-11-12 | 2024-09-30 | $-3.03 | $-2.78 |
| 2024-08-13 | 2024-06-30 | $-3.20 | $-2.80 |
| 2024-05-09 | 2024-03-31 | $-3.40 | $-3.00 |
| 2024-03-14 | 2023-12-31 | $-3.90 | $-3.50 |
| 2023-11-13 | 2023-09-30 | $-3.60 | $-3.20 |
| 2023-08-10 | 2023-06-30 | $-3.30 | $-3.40 |
| 2023-05-11 | 2023-03-31 | $-2.80 | $-3.10 |
| 2023-03-14 | 2022-12-31 | $-2.40 | $-2.50 |
| 2022-11-10 | 2022-09-30 | $-2.60 | $-2.50 |
| 2022-08-11 | 2022-06-30 | $-2.70 | $-2.50 |
| 2022-05-12 | 2022-03-31 | $-2.90 | $-2.60 |
| 2022-03-17 | 2021-12-31 | $-2.90 | $-2.50 |
| 2021-11-09 | 2021-09-30 | $-2.60 | $-2.80 |
| 2021-08-12 | 2021-06-30 | $-2.60 | $-2.50 |
| 2021-05-12 | 2021-03-31 | $-2.40 | $-2.50 |
| 2021-03-11 | 2020-12-31 | $-2.50 | $-2.20 |
| 2020-11-05 | 2020-09-30 | $-2.10 | $-2.30 |
| 2020-08-05 | 2020-06-30 | $-2.60 | $-2.20 |
| 2020-05-07 | 2020-03-31 | $-4.00 | $-3.00 |
| 2020-03-12 | 2019-12-31 | $-5.60 | $-5.00 |
| 2019-11-06 | 2019-09-30 | $-5.20 | $-4.80 |
| 2019-08-07 | 2019-06-30 | $-4.80 | $-4.60 |
| 2019-05-07 | 2019-03-31 | $-4.00 | $-4.00 |
| 2019-03-26 | 2018-12-31 | $-4.90 | $-3.00 |
| 2018-11-08 | 2018-09-30 | $-4.80 | $-3.00 |
| 2018-08-09 | 2018-06-30 | $-5.30 | $-33.10 |